LYON, France, July 3, 2024–(BUSINESS WIRE)–During its annual “BIG UP” event, French Tech Saint-Etienne Lyon awarded the BIG Start-up of the Year trophy, rewarding a start-up that is emblematic of the innovation and wealth of the region.
French Tech Saint-Etienne Lyon, a non-profit association created in 2015, promotes the creation, growth and internationalization of innovative companies in Lyon and Saint-Étienne.
Designated as one of the 17 French Tech Capitals by the French government until 2026, it is part of the roadmap of the French Tech Mission of the Ministry of the Economy, integrating the Lyon St Étienne region into a network of more than 100 French Tech Communities on five continents.
The French Tech Capitals and Communities serve as entry points for French start-ups into the global French Tech ecosystem.
On June 17, during the board of directors of French Tech Saint-Etienne Lyon, which brought together founders and managers of local start-ups and innovation players such as incubators, clusters and large groups, Brenus Pharma was named BIG Start-up of the year.
“By winning this award, Brenus Pharma stood out among the 12 pre-selected applications, meeting criteria of innovation and positive impact on our territory. We are proud to count Brenus Pharma among our members, now recognized as a promising player in our network, perfectly reflecting the values of La Mission French Tech“, declared Lucie Texier, general delegate of French Tech Saint-Etienne Lyon.
About French Tech Saint-Etienne Lyon:
Alongside innovation players, French Tech Saint-Etienne Lyon unites and drives the local ecosystem. It contributes to environmental and social transitions for a sustainable and inclusive territory of innovation and entrepreneurship. The association has more than 539 members, including 475 start-ups and 64 public and private partners.
About Brenus Pharma:
Brenus Pharma is a French biotechnology company developing a pioneering discovery platform, Stimulated-Tumor-Cell (STC), paving the way for a new generation of therapeutic vaccines against cancer.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240703702575/en/
Contacts
Marion BRUN
contact@brenus-pharma.com
